ASPN SEC Filings, Earnings & Splits

Aspen Aerogels filed an S-3 shelf registration statement, incorporating its audited financial statements by reference, with KPMG LLP consenting to the use of its audit report.

Aspen Aerogels reported Q3 2026 revenue of $85.2 million, up 71% quarter-over-quarter and above the high end of its outlook, with Adjusted EBITDA of $19.8 million. The company also issued Q4 2026 guidance for revenue of $60-75 million and Adjusted EBITDA of $5-13 million, and highlighted new data center and BESS commercial milestones.

Aspen Aerogels filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing an explosion incident at its East Providence facility, along with details of its MidCap credit facilities and customer concentration.

A Schedule 13G was filed regarding Aspen Aerogels Inc (ASPN), indicating a passive ownership position by an institutional or other holder. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.

An amendment to a Schedule 13D was filed for Aspen Aerogels Inc, indicating a change in a previously reported activist or large shareholder position. The filing text does not disclose specific ownership percentages or stated intentions.

Aspen Aerogels provided a financial outlook for the third quarter of 2026, including expectations for revenue, gross margins, and profitability, indicating positive forward guidance.